Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
2.410
+0.470 (24.23%)
At close: Nov 4, 2024, 4:00 PM
2.430
+0.020 (0.83%)
After-hours: Nov 4, 2024, 7:59 PM EST
Tenaya Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 33.29 | 33.16 | 31.08 | 18.41 | 7.81 | 4.56 |
Research & Development | 93.66 | 98.04 | 94.54 | 54.39 | 31.1 | 23.15 |
Operating Expenses | 126.95 | 131.19 | 125.62 | 72.81 | 38.91 | 27.71 |
Operating Income | -126.95 | -131.19 | -125.62 | -72.81 | -38.91 | -27.71 |
Interest & Investment Income | 6.09 | 7.06 | 1.95 | 0.11 | 0.09 | 0.45 |
Other Non Operating Income (Expenses) | 0.12 | 0.05 | 0 | -0.02 | 0.39 | 1.03 |
EBT Excluding Unusual Items | -120.74 | -124.08 | -123.67 | -72.72 | -38.44 | -26.23 |
Gain (Loss) on Sale of Assets | - | - | - | - | -0.03 | -0.01 |
Other Unusual Items | - | - | - | - | 0.08 | 0.01 |
Pretax Income | -120.74 | -124.08 | -123.67 | -72.72 | -38.4 | -26.23 |
Net Income | -120.74 | -124.08 | -123.67 | -72.72 | -38.4 | -26.23 |
Net Income to Common | -120.74 | -124.08 | -123.67 | -72.72 | -38.4 | -26.23 |
Shares Outstanding (Basic) | 79 | 74 | 45 | 18 | 1 | 1 |
Shares Outstanding (Diluted) | 79 | 74 | 45 | 18 | 1 | 1 |
Shares Change (YoY) | 29.65% | 64.61% | 152.75% | 1724.33% | 28.62% | - |
EPS (Basic) | -1.53 | -1.68 | -2.76 | -4.10 | -39.50 | -34.71 |
EPS (Diluted) | -1.53 | -1.68 | -2.76 | -4.10 | -39.50 | -34.71 |
Free Cash Flow | -98.88 | -103.31 | -125.05 | -85.93 | -45.21 | -27.02 |
Free Cash Flow Per Share | -1.25 | -1.40 | -2.79 | -4.85 | -46.51 | -35.75 |
EBITDA | -118.31 | -122.51 | -119.15 | -69.85 | -36.43 | -25.72 |
D&A For EBITDA | 8.64 | 8.69 | 6.47 | 2.96 | 2.48 | 1.99 |
EBIT | -126.95 | -131.19 | -125.62 | -72.81 | -38.91 | -27.71 |
Source: S&P Capital IQ. Standard template.
Financial Sources.